NRX Pharmaceuticals, Inc.
Q3 2025 13F Holders
Symbol
NRXP
CUSIP
629444209
Type
Equity
Class
COM NEW
Num filings
28
Total reported value, excl. options
$13.0 M
Compare 2025 Q3 to
2026 Q2
2026 Q1
2025 Q4
2025 Q2
2025 Q1
2024 Q4
2024 Q3
2024 Q2
Manager
Report Date
Value ($000)
Shares
Option Type